|Livestock vaccine in Viet Nam is mostly imported, creating obstacles to the prevention and control of animal diseases.— Photo canthotv
HA NOI (VNS)— Livestock vaccine in Viet Nam is mostly imported, creating obstacles to the prevention and control of animal diseases.
The statement was made by Nguyen Thu Thuy, Deputy Director of the Ministry of Agriculture and Rural Development's Animal Health Department.
Only five out of 109 companies producing veterinary medicine across the country are registered to produce vaccine.
These five companies currently help provide the country with a total of 86 different kinds of vaccine, nearly five per cent of the products allowed to be put into circulation.
Whereas, Viet Nam currently has 2,000 other kinds of vaccine produced by 209 companies across 36 countries worldwide including China, France, Netherlands, Switzerland, Spain.
"Because of being passive in supplying vaccine, plans for livestock inoculation against epidemics could be affected when the supply is interrupted. As a result, the damage would be more extensive", Viet Nam Poultry Association Vice Chairman Doan Xuan Truc said, emphasizing that it would be difficult to find another kind of vaccine to replace it when a virus type changed.
Most vaccines used to vaccinate livestock against bird flu, foot-and-mouth disease, porcine reproductive and respiratory syndrome virus (PRRSV) - also known as blue-ear pig disease - were imported.
"Last year, 9.7 million doses of vaccine preventing blue-ear pig disease were imported, 6.3 million doses higher than the figure of 2010", Thuy said.
In April, the Government allowed the Ministry of Agriculture and Rural Development to buy 40 million doses of vaccine, imported from China and worth over VND 10 billion (US$476,000), to keep on standby for bird flu.
"The vaccine production process is extremely costly. Besides, the Government hasn't had financial policies which could encourage scientists and drug makers to make vaccine. So, livestock vaccine production in the country has met many difficulties," Thuy said.
Therefore, to make good the shortcomings, policies which will help develop vaccine production, business and distribution will be built and submitted for the government's approval by the department.
Accordingly, companies, as well as projects researching and producing vaccines, will get much preferential treatment in terms of capital and land allocation.
"Priority will be given to using vaccine produced by domestic companies for livestock inoculation in the country," Thuy said, adding that only when the country couldn't manufacture livestock vaccine, imported vaccine would be used.
The Government will give further attentiozn to training pharmaceutical human resources, and invest in techniques for researching and manufacturing vaccine.
"Domestic companies and research institutes should expand international co-operation in researching and manufacturing vaccine, which will help improve research skills and technology transfer", Truc said. — VNS